Bahamas

Resilience System


You are here

Government

ANALYSIS: Why emergency COVID-vaccine approvals pose a dilemma for scientists

After a flurry of positive results from clinical trials of COVID-19 vaccines, developers are now seeking ‘emergency use’ approvals, which could see these immunizations deployed in potentially tens of millions of people. But scientists are concerned that this kind of early deployment could compromise the ongoing clinical trials that seek to show conclusively how well the vaccines work.

Problem, Solution, SitRep, or ?: 

Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Government
howdy folks
Page loaded in 0.986 seconds.